These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 7478614
1. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Nayeri S, Danielsson C, Kahlen JP, Schräder M, Mathiasen IS, Binderup L, Carlberg C. Oncogene; 1995 Nov 02; 11(9):1853-8. PubMed ID: 7478614 [Abstract] [Full Text] [Related]
2. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity. Quack M, Clarin A, Binderup E, Björkling F, Hansen CM, Carlberg C. J Cell Biochem; 1998 Dec 01; 71(3):340-50. PubMed ID: 9831071 [Abstract] [Full Text] [Related]
3. Metabolism of the vitamin D3 analogue EB1089 alters receptor complex formation and reduces promoter selectivity. Quack M, Mørk Hansen C, Binderup E, Kissmeyer AM, Carlberg C. Br J Pharmacol; 1998 Oct 01; 125(4):607-14. PubMed ID: 9831892 [Abstract] [Full Text] [Related]
4. Functional characterization of a 1,25-dihydroxyvitamin D3 receptor binding site found in the rat atrial natriuretic factor promoter. Kahlen JP, Carlberg C. Biochem Biophys Res Commun; 1996 Jan 26; 218(3):882-6. PubMed ID: 8579609 [Abstract] [Full Text] [Related]
5. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Schräder M, Nayeri S, Kahlen JP, Müller KM, Carlberg C. Mol Cell Biol; 1995 Mar 26; 15(3):1154-61. PubMed ID: 7862109 [Abstract] [Full Text] [Related]
6. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs. Quack M, Carlberg C. Mol Pharmacol; 1999 Jun 26; 55(6):1077-87. PubMed ID: 10347251 [Abstract] [Full Text] [Related]
7. Functional characterization of a novel type of 1 alpha,25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter. Schräder M, Kahlen JP, Carlberg C. Biochem Biophys Res Commun; 1997 Jan 23; 230(3):646-51. PubMed ID: 9015378 [Abstract] [Full Text] [Related]
8. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells. Agadir A, Shealy YF, Hill DL, Zhang X. Cancer Res; 1997 Aug 15; 57(16):3444-50. PubMed ID: 9270011 [Abstract] [Full Text] [Related]
9. Vitamin D3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Schräder M, Müller KM, Nayeri S, Kahlen JP, Carlberg C. Nature; 1994 Aug 04; 370(6488):382-6. PubMed ID: 8047145 [Abstract] [Full Text] [Related]
10. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C. J Cell Biochem; 1997 Sep 15; 66(4):552-62. PubMed ID: 9282333 [Abstract] [Full Text] [Related]
11. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation. Nayeri S, Mathiasen IS, Binderup L, Carlberg C. J Cell Biochem; 1996 Sep 01; 62(3):325-33. PubMed ID: 8872604 [Abstract] [Full Text] [Related]
12. Ligand-triggered stabilization of vitamin D receptor/retinoid X receptor heterodimer conformations on DR4-type response elements. Quack M, Carlberg C. J Mol Biol; 2000 Feb 25; 296(3):743-56. PubMed ID: 10677278 [Abstract] [Full Text] [Related]
13. The 1,25-dihydroxyvitamin D3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. Carlberg C, Mathiasen IS, Saurat JH, Binderup L. J Steroid Biochem Mol Biol; 1994 Nov 25; 51(3-4):137-42. PubMed ID: 7981122 [Abstract] [Full Text] [Related]
14. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Drissi H, Pouliot A, Koolloos C, Stein JL, Lian JB, Stein GS, van Wijnen AJ. Exp Cell Res; 2002 Apr 01; 274(2):323-33. PubMed ID: 11900492 [Abstract] [Full Text] [Related]
15. The potent anti-proliferative effect of 20-epi analogues of 1,25 dihydroxyvitamin D3 in human breast-cancer MCF-7 cells is related to promoter selectivity. Mørk Hansen C, Danielsson C, Carlberg C. Int J Cancer; 1996 Sep 04; 67(5):739-42. PubMed ID: 8782667 [Abstract] [Full Text] [Related]
16. Vitamin D3- and retinoic acid-induced monocytic differentiation: interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Botling J, Oberg F, Törmä H, Tuohimaa P, Bläuer M, Nilsson K. Cell Growth Differ; 1996 Sep 04; 7(9):1239-49. PubMed ID: 8877104 [Abstract] [Full Text] [Related]
17. Differential effects of 20-epi vitamin D analogs on the vitamin D receptor homodimer. Koszewski NJ, Reinhardt TA, Horst RL. J Bone Miner Res; 1999 Apr 04; 14(4):509-17. PubMed ID: 10234571 [Abstract] [Full Text] [Related]
18. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG. J Cell Physiol; 2001 Sep 04; 188(3):383-93. PubMed ID: 11473365 [Abstract] [Full Text] [Related]
19. Differential nuclear receptor signalling from DR4-type response elements. Quack M, Frank C, Carlberg C. J Cell Biochem; 2002 Sep 04; 86(3):601-12. PubMed ID: 12210766 [Abstract] [Full Text] [Related]
20. Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD, Martin MB. J Cell Biochem; 1999 Dec 15; 75(4):640-51. PubMed ID: 10572247 [Abstract] [Full Text] [Related] Page: [Next] [New Search]